| Care and Maintenance of Vision |
1 |
1 |
| Exudative ARMD |
0 |
0.9 |
| Biologic Therapy |
0 |
0.84 |
| Genomic Medicine |
0 |
0.71 |
| Gene Therapy |
0 |
0.56 |
| Healthcare and Medical Technology |
0 |
0.54 |
| Retinal Diseases |
0 |
0.53 |
| Clinical Research |
0 |
0.35 |
| Orbit |
0 |
0.35 |
| Retina |
0 |
0.35 |
| Vascular Endothelial Growth Factor |
0 |
0.35 |
| Corticosteroids |
0 |
0.28 |
| Uveitis |
0 |
0.18 |
| Cytokines |
0 |
0.14 |
| Immunocompromise |
0 |
0.14 |
| Receptors |
0 |
0.14 |
| Steroids |
0 |
0.14 |
| Tissue |
0 |
0.14 |
| Vitreoretinal Surgery |
0 |
0.1 |
| Patient Safety |
0 |
0.09 |
| Adverse Effects |
0 |
0.07 |
| Artificial Intelligence |
0 |
0.07 |
| Biomarker |
0 |
0.07 |
| Face |
0 |
0.07 |
| Fundus |
0 |
0.07 |
| Intraocular Inflammation |
0 |
0.07 |
| Macular Degeneration |
0 |
0.99 |
| Nerve |
0 |
0.07 |
| North Carolina |
0 |
0.07 |
| Pharmacokinetics |
0 |
0.07 |
| Statistics |
0 |
0.07 |
| Stress |
0 |
0.07 |
| Surgery |
0 |
0.07 |
| Tumor |
0 |
0.07 |
| Visual Acuity |
0 |
0.07 |
| Washington |
0 |
0.07 |